1Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK trial registry. J Am Coll Cardiol,2000,36 : 1063-1070.
2Antman EM. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the A- merican College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation,2004,110 : e82-92.
3Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coil Cardiol,2000,36 : 1123-1129.
4Mishra S, Chu WW, Torguson R, et al. Role of Prophylactic Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Percutaneous Coronary Intervention. Am J Cardiol,2006,98:608-612.
5Chen EW, Canto JG, Parsons LS, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation ,2003,108:951-957.
